A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Trichosanthin

DRUG

Zidovudine

Trial Locations (8)

10011

Saint Vincent's Hosp and Med Ctr, New York

33125

Miami Veterans Administration Med Ctr, Miami

33614

Infectious Disease Research Institute Inc, Tampa

60611

Northwestern Univ, Chicago

94103

ViRx Inc, San Francisco

94108

Dr Larry A Waites, San Francisco

94109

Saint Francis Mem Hosp, San Francisco

94110

UCSF - San Francisco Gen Hosp, San Francisco

Sponsors
All Listed Sponsors
lead

Genelabs Technologies

INDUSTRY